Last reviewed · How we verify

NCT06888791

US-guided Hydro Dissection vs Fluoroscopy-guided Hydro Dissection for Adhesive Capsulitis

Recruiting now NA Last updated 21 March 2025
What this trial tests

NA trial testing US-guided Hydro Dissection in Shoulder Pain in 44 participants. Currently enrolling.

Timeline
25 February 2025
Primary endpoint
25 September 2025
30 December 2025

Quick facts

Lead sponsorDiskapi Teaching and Research Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment44
Start date25 February 2025
Primary completion25 September 2025
Estimated completion30 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Diskapi Teaching and Research Hospital

Who can join

Adults 18 to 80, any sex, with Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the differences in joint range of motion, Visual Analog Scale (VAS) scores, and the Shoulder Pain and Disability Index (SPADI) outcomes in patients with adhesive capsulitis (frozen shoulder) who undergo hydrodilatation therapy with either ultrasound (USG) or fluoroscopy guidance, in addition to a suprascapular nerve block.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

Other Diskapi Teaching and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06888791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing